Second WHO Global Consultation on Regulatory Requirements for Xenotransplantation Clinical Trials

October 17-19 2011, WHO, Geneva, Switzerland

Overview

The charge to the consultation was: 
1) To review the current status of xenotransplantation science and practice;
2) To determine whether updates to the Changsha Communiqué's guidance to
WHO, Member State health regulatory authorities, and study investigators
and/or sponsors of xenotransplantation trials are required; and
3) To discuss and refine draft guidance for infectious disease surveillance,
prevention, and response appropriate to support various probable clinical
xenotransplantation trial scenarios.

 

WHO Team
Blood and other Products of Human Origin (BTT), Health Product Policy and Standards (HPS), Technical Standards and Specifications (TSS)
Editors
World Health Organization
Number of pages
37
Reference numbers
WHO Reference Number: WHO/HTP/EHT/CPR/2011.01